Related Experiment Video
Updated: Dec 21, 2025

11:58
Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
Published on: August 11, 2015
16.0K
Mechanical Thrombectomy in Nonagenarians: A Propensity Score Matched Analysis
Shashank Agarwal1, Jeffrey Huang2, Erica Scher1
1Department of Neurology, NYU School of Medicine, New York, NY, USA.
Summary
Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in nonagenarians shows comparable outcomes to younger patients. Nearly half of nonagenarians achieved good discharge disposition, similar to those aged 69 and under.
Area of Science:
- Neurology
- Interventional Cardiology
- Geriatric Medicine
Background:
- Limited data exists on the outcomes of mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in nonagenarians.
- This study compares procedural and discharge outcomes of MT in nonagenarians versus younger patients.
Purpose of the Study:
- To compare procedural and discharge outcomes of MT for AIS in nonagenarians versus a younger cohort (≤69 years).
- To evaluate the efficacy and safety of MT in the oldest patient demographic.
Main Methods:
- Propensity score-matching was used to compare nonagenarians (≥90 years) with patients aged ≤69 who underwent MT for AIS.
- Exclusion of patients aged 70-89 allowed for a direct comparison with a younger cohort representative of seminal MT trials.
- Good discharge disposition was defined as discharge to home or acute rehabilitation.
Main Results:
- Successful recanalization (mTICI≥2b) was achieved in 90% of both nonagenarians and the younger cohort.
- Revascularization and door-to-puncture times were similar between the groups.
- Symptomatic intracranial hemorrhage and in-hospital death rates trended lower in nonagenarians.
- Good discharge disposition was observed in 44% of nonagenarians versus 51% of the younger cohort (P=0.496).
Conclusions:
- Mechanical thrombectomy in nonagenarians with AIS demonstrates high rates of successful recanalization.
- Outcomes, including discharge disposition, are comparable to a significantly younger patient cohort (≤69 years).
- MT is a viable treatment option for select nonagenarian patients with AIS.

